Ping was the brave first graduate student to join what at the time was a two people lab (Andrea and Paul). His graduate work in the lab resulted in the identification of the miR-19 as a key Myc effector in lymphomagenesis (Mu, Han et al, Genes Dev 2009) and in prostate cancer (Han, Vidigal, Mu et al., Nat Genet 2015).
After graduating from our lab Ping did a brilliant postdoc with Charles Sawyers lab, in the HOPP program at MSKCC and he is now an Assistant Professor at the University of Texas, South Western, Dallas. His broad interests include understanding the mechanism of resistance to targeted therapy and developing novel therapeutic approaches to overcome it. One specific interest of his research is understanding how epigenetic regulation modulates the lineage plasticity of tumor cells and confers resistance. You can reach him at: email@example.com
Evelyn began her scientific training while working in academic and industry laboratories dedicated to understanding cancer biology. Upon joining the Ventura lab, she went on to investigate the role of miR-17~92 in mammalian development. Her work led to the identification of the first known example of a germline mutation of a miRNA gene leading to a syndromic developmental defect in humans. Evelyn currently partners with a variety of pharmaceutical companies developing strategic medical communications for her clients.
Yoon-Chi was the first postdoctoral fellow to joint the lab, back in 2009. During her stay in the lab she first collaborated with Ping to study the role of miR-19 in lymphomagenesis (Mu, Han, et al., Genes Dev 2009) and then she worked on generating and characterizing an allelic series of miR-17~92 mutant (Han, Vidigal, Mu et al., Nature Genetics 2015). She is now a senior scientist studying immunology and cancer at Pfizer. Her contact: firstname.lastname@example.org
Current position: Lab Head at Novartis
During her time in our lab Carla generated and characterized mutant mice harboring targeted deletion of miR-34a, miR-34b, and miR-34c, three miRNAs that are direct transcriptional targets of the p53 tumor suppressor (Concepcion et al. PLoS Genetics, 2012). She also worked to develop a novel method to identify miRNA-mRNA interactions in vivo (manuscript in preparation).
After graduating, Carla followed in her mentor’s footsteps and joined Tyler Jacks lab at MIT for her postdoctoral training.
Current position: Postdoctoral fellow in Tyler Jacks lab, MIT
I was the Administrative Assistant for the Ventura lab from 2009-2014. I very much enjoyed working with Andrea and all the members of the lab. Whether it was applying for a grant, a birthday, getting a paper published, or a lab outing, we always managed to have a great time and work well together. I am currently the Research Fund Management Specialist in ORPA Operations where our team supports the pre and post award management for SKI. I process all HR paperwork for SKI and review all the awarded grants in our database Grants Central before receiving a fund number.
Current title: Research Fund Management Specialist @MSKCC
Ciro was the brave second postdoc to join the Ventura Lab. He earned his PhD at TIGEM, Telethon Institute of Genetics and Medicine in Napoli – Italy, where he focused on the study of visual system development in health and disease and on developing novel gene therapy approaches for inherited retinal disorders. During his time in the Ventura lab, he identified long non-coding RNAs involved in cancer and examined their function in vivo by generating mouse models. In addition, Ciro was interested in technology development and modified the Cas9 system to increase efficiency of homology directed repair. In 2016, he obtained a position as ‘scientist for allele design’ at Regeneron.
You can reach Ciro at www.linkedin.com/in/cirobonetti
Camilo is a surgeon with an interest in academic surgical oncology. As part of his research fellowship in the Hepatopancreatobiliary surgery service at Sloan Kettering, he worked in the Ventura lab during 2012-2013 on a translational project identifying deregulated microRNAs in cholangiocarcinoma as potential biomarkers. He is currently completing a Complex General Surgical Oncology Fellowship at Memorial Sloan Kettering Cancer Center.
Current job: Surgical Oncology Fellow – Memorial Sloan Kettering Cancer Center
Maurizio was born in Sicily like Andrea and grew up on his family winery. He started medical school at San Raffaele University in Milan and soon became interested in oncology. He came to the lab as a visiting student to approach the bench side of cancer research. The experience was transformative and motivated him to leave the clinic to focus on basic cancer research. After completing his studies he came back to MSKCC in the Armstrong lab supported by an American Italian cancer Foundation Fellowship and in 2014 he moved to Boston to start a PhD at Harvard University. He currently works in the Zon lab at Boston Children`s Hospital as a Boheringer Ingelheim PhD Fellow using mouse and zebrafish to understand melanoma metastatic progression and cancer clonal evolution. He also teaches at Harvard College about evolutionary and regenerative medicine. In his free time he enjoys wine, cooks risotto for friends, travels and thinks about mars terraforming.
Current position: PhD Candidate in Leonard Zon lab, Harvard University – Boston Children`s Hospital
Current position: Clinical Research Associate at Quintiles
Current position: Graduate Student at Brunel University, London
Dirk Spencer was a high school intern in the Ventura lab. After graduating high school he continued to do research under the guidance of Professor Simon Gilroy at the University of Wisconsin-Madison. Dirk is now a first year graduate student in the Biology PhD program at Stanford University. He is interested in determining how multicellular organisms regulate growth and differentiation in addition to elucidating the mechanism that enable organisms perceive and respond to environmental stimuli. During the course of his PhD Dirk aims to refine our understanding of asymmetric cell divisions, cell polarity, and specialized subcellular microdomains within the context of development and environmental sensing.
Yu Wah is from a small town village located in the South of The Netherlands. She obtained her bachelor degree in biology at Utrecht University. Subsequently, she continued her Master studies majoring in molecular and cellular life sciences. She joined the Ventura lab for a 6-month internship in 2016. Yu Wah’s other interests are yoga, exploring the city, visiting concerts and photography.
Alexendar Perez is from Pasadena, California. He obtained his undergraduate degree in Computational Biology from Cornell University in Ithaca, New York. He is a student in the Tri-Institutional MD/Ph.D program. After brilliantly defending his Ph.D in Bioinformatics and— jointly mentored by Andrea Ventura and Christina Leslie—Alex is now completing his medical training. He intends to train in oncology like his boss. Alex’s hobbies include studying mathematics, scripting, and reading nonfiction. For his graduate work, in 2017 Alex was named as one of the ’30 under 30′ by Forbes!